Skip to content
Search

Latest Stories

Members of the Senedd discuss on supporting pharmacists in Wales

Last week, the Members of the Senedd (MSs) debated on how to support pharmacists, while agreeing to the vital contribution made by the pharmacists across the health services in Wales.

The growing role of independent prescribing pharmacists, the new clinical community pharmacy contract and the work on developing an electronic prescribing system in Wales, were also discussed.


The debate was instigated after several MSs met with the Royal Pharmaceutical Society (RPS) earlier in March and were told of the worrying results of the latest RPS member wellbeing survey and the urgent need for support for pharmacy teams.

"Specifically, we called for greater investment in the pharmacy workforce, protected learning time within working hours and action to ensure pharmacy teams are given access to, and enabled to take appropriate rest breaks. A motion for debate was subsequently tabled," said RPS.

Nine MSs from across all parties spoke in the debate with Eluned Morgan, the Minister for Health and Social Care replying on behalf of the Welsh Government. Common themes that ran throughout the debate were:

  • the need to urgently tackle the worrying results of the RPS wellbeing survey through further workforce investment, protected learning time and appropriate rest breaks.
  • recognition of the dedication of the pharmacists in Wales across sectors throughout the pandemic in maintaining services, developing new treatments for Covid-19 and as part of the vaccine roll out.
  • the need for the clinical skills of pharmacists to be fully integrated and recognised as a core part of the NHS.

Commenting on the debate, RPS Wales chair Cheryl Way, said: “The last few years have been particularly challenging for pharmacists and their teams. At RPS we’ve been clear to MSs that there must be renewed support and investment for the profession in Wales, particularly around protected learning time and wellbeing.

We were delighted with the unanimous, cross-party agreement on our calls in Senedd and will continue our positive engagement with the Welsh Government and MSs to make sure the changes that our members need come into practice.”

The following Motion was agreed unanimously:

To propose that the Senedd:

  1. Recognises the vital work pharmacists have undertaken throughout the pandemic, as well as their crucial role in supporting primary and secondary care.
  2. Welcomes the new National Clinical Community Pharmacy Service coming into force on 1 April 2022.
  3. Is concerned by results from the Royal Pharmaceutical Society’s 2021 Workforce Wellbeing Survey, which shows that nine out of 10 respondents were at high risk of burnout and one in three had considered leaving the profession altogether.
  4. Calls on the Welsh Government to:
  5. a) urgently reduce bureaucracy by introducing e-prescriptions and providing access to medical records;
  6. b) ensure dedicated protected learning time within working hours for wellbeing and study;
  7. c) invest in the pharmacy workforce to train more pharmacy staff and upskill existing staff.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less